Shearman & Sterling advised Ibere Pharmaceuticals on the deal.Ibere Pharmaceuticals, a blank check company formed for the purpose of effecting a merger in the pharmaceutical and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
